IDEXX LABORATORIES INC /DE Effective Income Tax Rate Reconciliation Fdii Percent
IDEXX LABORATORIES INC /DE (IDXX) reported Effective Income Tax Rate Reconciliation Fdii Percent of 1.30% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation fdii percent for fiscal 2024 was 1.30%, a 7.14% decline from fiscal 2023.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation fdii percent for fiscal 2023 was 1.40%, a 17.65% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation fdii percent for fiscal 2022 was 1.70%, a 41.67% increase from fiscal 2021.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation fdii percent for fiscal 2021 was 1.20%.
| Period end | Effective Income Tax Rate Reconciliation Fdii Percent 12 month |
|---|---|
| 2024-12-31 | 1.30% 10-K · filed 2026-02-20 |
| 2023-12-31 | 1.40% 10-K · filed 2026-02-20 |
| 2022-12-31 | 1.70% 10-K · filed 2025-02-21 |
| 2021-12-31 | 1.20% 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |